Synapse

← Neurology Perspectives

Papers in Neurology Perspectives

Page 1 · newest first

  1. Sociodemographic determinants and mortality due to Alzheimer disease in Argentina: An eco-epidemiological analysis (2000–2019)Neurology Perspectives · 2026
  2. Eco-epidemiological relationships between environmental factors and neurodegenerative diseases in ArgentinaNeurology Perspectives · 2026
  3. Projections of the neurology specialtyNeurology Perspectives · 2026
  4. Analysis of the safety and efficacy of the generic substitution of branded antiseizure medications: a systematic literature reviewNeurology Perspectives · 2026
  5. CLIPPERS syndrome with more than 12-year follow-up: a case reportNeurology Perspectives · 2026
  6. Leptomeningeal carcinomatosis associated with anti-NMDAR encephalitis: A case report and literature reviewNeurology Perspectives · 2026
  7. Visuoperceptual and visuospatial alterations in neurodegenerative diseases: a narrative reviewNeurology Perspectives · 2026
  8. Very late-onset myasthenia gravis: Clinical characteristics and prognosis at a secondary hospitalNeurology Perspectives · 2026
  9. Clinical efficacy and safety profile of biological therapies versus standard interventions in MS and NMOSD relapses: A systematic reviewNeurology Perspectives · 2026
  10. Expanding the epidemiologic spectrum of TTR amyloidosis in Spain. A new epidemiological focus in ZamoraNeurology Perspectives · 2026
  11. Post-ischemic stroke epilepsy in adults: A cross-sectional studyNeurology Perspectives · 2026
  12. Frequency of area postrema syndrome in a Peruvian cohort of patients with neuromyelitis optica spectrum disorderNeurology Perspectives · 2026
  13. 22537 - Elevación Atípica De Troponinas en Ictus Agudo: Desafíos Diagnósticos Y Relevancia Clínica en La Valoración CardiacaNeurology Perspectives · 2025
  14. 22821 - Continuación Del Tratamiento Anticoagulante en La Fase Aguda Del Infarto Cerebral Y Fuente Cardioembólica MayorNeurology Perspectives · 2025
  15. Riesgo de infección e inmunosupresión en esclerosis múltiple remitente-recurrente tratada con Alemtuzumab: seguimiento durante 3,5 añosNeurology Perspectives · 2026
  16. Prediction of cerebral white matter lesions using a multilayer perceptron applied to routine clinical dataNeurology Perspectives · 2026
  17. Locus coeruleus: Clinical aspects of its involvement in Parkinson's diseaseNeurology Perspectives · 2026
  18. Efficacy of coenzyme Q10 on fatigue in patients with multiple sclerosis: A systematic reviewNeurology Perspectives · 2026
  19. Usefulness of functional assessment of advanced activities of daily living compared with cognitive assessment, as a predictor of mild cognitive impairment in adults older than 60 years: A systematic reviewNeurology Perspectives · 2026
  20. Ocrelizumab reduces progression of brain atrophy in patients with multiple sclerosisNeurology Perspectives · 2025
  21. Comparative study of infusion-related reactions to anti-CD20 drugs in neuroimmunological diseases of the central nervous system: a retrospective analysis of ocrelizumab and rituximab treatmentsNeurology Perspectives · 2025
  22. Diagnostic and therapeutic challenges in narcolepsy: From childhood to complex comorbidity through 3 clinical casesNeurology Perspectives · 2025
  23. Update on diagnosis and treatment of aneurysmal subarachnoid hemorrhage: A literature reviewNeurology Perspectives · 2025
  24. Hematological parameters: Are they predictors of ischemic stroke subtypes?Neurology Perspectives · 2025
  25. Bridging the gap: Unveiling the gut's influence on Parkinson's disease through probiotic interventionsNeurology Perspectives · 2025
  26. Taste disorders due to unilateral upper molar extraction in juvenile and adult albino ratsNeurology Perspectives · 2025
  27. Multiple sclerosis and rheumatic diseases: Rheumatoid arthritis, antiphospholipid syndrome, and systemic lupus erythematosusNeurology Perspectives · 2025
  28. Inflammatory bowel disease and multiple sclerosisNeurology Perspectives · 2025
  29. Other autoimmune diseases and multiple sclerosisNeurology Perspectives · 2025
  30. Findings in orofacial praxis in clinical swallow examination in patients with neurogenic oropharyngeal dysphagiaNeurology Perspectives · 2025
  31. The pillars of migraine diagnosis and treatment: Information from primary care physicians in ColombiaNeurology Perspectives · 2025
  32. Impact of COVID-19 on physiotherapy for patients with multiple sclerosis in Spain: Adaptation and challenges in the implementation of telerehabilitationNeurology Perspectives · 2025
  33. Adult-onset cerebral X-linked adrenoleukodystrophy presenting with frontal lobe syndrome caused by a de novo ABCD1 gene mutation (c.1415_1416delAG, p.Gln472fs*83)Neurology Perspectives · 2025
  34. Ibero-American consensus statement on migraine treatmentNeurology Perspectives · 2024
  35. Functional cognitive disorder: Beyond pseudodementiaNeurology Perspectives · 2024
  36. Association of depression in multiple sclerosis with fatigue, sleep disturbances, disability, and health-related quality of life: Outcomes of a cross-sectional studyNeurology Perspectives · 2024
  37. Predictors of mortality in dementia: A systematic review and meta-analysisNeurology Perspectives · 2024
  38. Early prognostic factors in acute inflammatory demyelinating polyneuropathy: Role of neurofilamentsNeurology Perspectives · 2024
  39. COVID-19 disease severity and affectations in electroneuromyographic studiesNeurology Perspectives · 2024
  40. Sensitivity and specificity of the ocular movements test (HINTS) in the detection of central acute vestibular syndromeNeurology Perspectives · 2024
  41. Switching of monoclonal antibodies against the calcitonin gene-related peptide or its receptor in migraine. Results from a Spanish CohortNeurology Perspectives · 2024
  42. Frequency of and factors associated with underdosing of direct oral anticoagulants in patients with ischaemic stroke and atrial fibrillationNeurology Perspectives · 2024
  43. Relationship between brain-derived neurotrophic factor and mild to moderate cognitive impairment in the older Mexican populationNeurology Perspectives · 2024
  44. Genetics of Parkinson's disease: Dominant forms and GBANeurology Perspectives · 2024
  45. Impact of the COVID-19 pandemic on the physical activity habits of people with multiple sclerosis in SpainNeurology Perspectives · 2024
  46. Symptomatic Tarlov cysts: A case series and effectiveness of multimodal rehabilitation plus pharmacological treatmentNeurology Perspectives · 2024
  47. Genetics of Parkinson´s disease: Recessive formsNeurology Perspectives · 2024
  48. Physical activity, mental health, support networks, lifestyle, and memory in older adults during the COVID-19 pandemicNeurology Perspectives · 2024
  49. Autoimmune-associated epilepsy in an outpatient epilepsy clinic: A retrospective studyNeurology Perspectives · 2023
  50. A novel case of Bálint syndrome with hallucinatory palinopsia following hypoglycemic coma: opening new doors to the origin of palinopsiaNeurology Perspectives · 2023